Rinderknecht, Fatuma-Ayaan https://orcid.org/0000-0001-6302-7348
Naik, Haley
Article History
Received: 10 May 2024
Revised: 11 October 2024
Accepted: 27 November 2024
First Online: 9 December 2024
Declarations
:
: Exempt by the University of California, San Francisco Institutional Review Board (IRB #19–27407).
: All participants completed an online consent form prior to participating in the survey.
: Patients signed informed consent regarding publishing their data.
: Dr. Naik has the following conflicts of interest: consulting: Abbvie, Medscape, SonomaBio, UCB, and Novartis; shares: Radera, Inc.; others: executive board member, Hidradenitis Suppurativa Foundation; and associate editor, JAMA Dermatology.